Odaily Planet Daily News Bitcoin investment company Parataxis Holdings LLC announced that it has reached a final investment agreement of 25 billion won with Bridge Biotherapeutics, Inc., which enables it to obtain the latter's controlling stake. After the transaction is completed, Bridge Biotherapeutics will be renamed Parataxis Korea and continue to be listed on the Korean GEM market KOSDAQ. The company expects to announce more details about the transaction after the shareholders' meeting in August. (PRNewswire)
Previously, Parataxis Holdings LLC planned to go public through a merger with special purpose acquisition company SilverBox Corp IV, and the two parties had signed a non-binding letter of intent.